Home/Filings/4/0001104659-24-001820
4//SEC Filing

Shemesh Shay 4

Accession 0001104659-24-001820

CIK 0001875558other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 4:30 PM ET

Size

4.9 KB

Accession

0001104659-24-001820

Insider Transaction Report

Form 4
Period: 2024-01-03
Shemesh Shay
Chief Dev. & Ops. Officer
Transactions
  • Award

    Common Stock

    2024-01-03+130,0001,491,955 total
Footnotes (2)
  • [F1]The restricted stock will vest according to the following schedule: one-third on each of 01/3/2025, 01/3/2026, and 01/3/2027.
  • [F2]Includes 353,399 shares of restricted stock.

Issuer

Nuvectis Pharma, Inc.

CIK 0001875558

Entity typeother

Related Parties

1
  • filerCIK 0001896056

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:30 PM ET
Size
4.9 KB